Liminatus Pharma, Inc. (LIMN)
Nasdaq: LIMN · Biological Products, (No Diagnostic Substances) · Cerritos, CA · filing with the SEC since 2023
Filings
93 filings since 2017 beside 16 insider forms · and emerging growth company · read from EDGAR on Nov 13, 2026Due next and emerging growth company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jul 13, 2026.
Filings a yearinsider forms included
5175235
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 8 times in the last 36 months, the newest Sep 29, 2026.Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Jul 11, 2025.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest May 6, 2025.SEC letters: 20 in the last 36 months, the newest Feb 11, 2026.A late-filing notice, Form NT 10-Q, filed Aug 15, 2025.A late-filing notice, Form NT 10-Q, filed May 15, 2025.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
Nov 3, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Nov 2, 2026
Sep 29, 2026
8-K items 3.01, 7.01, 9.01
Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report
Sep 24, 2026
Aug 18, 2026
8-K items 3.01, 3.03, 5.03, 7.01, 9.01
Listing warning from its exchange; Change to shareholders' rights; Charter, bylaw or fiscal-year change; Investor disclosure (Regulation FD) · Current report
Jul 24, 2026
8-K items 3.01, 8.01, 9.01
Listing warning from its exchange; Other event · Current report
Jul 20, 2026
Jul 6, 2026
8-K items 1.01, 2.01, 3.02, 5.03, 9.01
Major agreement signed; Purchase or sale of a business completed; Shares sold without registration; Charter, bylaw or fiscal-year change · Current report
Jun 29, 2026
Jun 3, 2026
8-K items 1.01, 3.02, 3.03, 8.01, 9.01
Major agreement signed; Shares sold without registration; Change to shareholders' rights; Other event · Current report
Feb 18, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Feb 17, 2026
Feb 9, 2026
8-K items 1.01, 3.02, 9.01
Major agreement signed; Shares sold without registration · Current report
Feb 6, 2026
40 of 93 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.